Our Ref: APURE 027/2020 13 August 2020 Subject Clarification on Second Quarter’s Operating Performance (2/2020) Attn. To President The Stock Exchange of Thailand The company clarifies causes and
Exchange Commission No. Kor Dor. 21/2552 Re: Licensing Derivatives Exchange and Derivatives Clearing House __________________ By virtue of Section 6, Section 9, Paragraph 3 of Section 54 and Paragraph 3 of
The Stock Exchange of Thailand The Company wishes to present the Management Discussion & Analysis (MD&A) on the operating and financial status for the 1st quarter of 2018. The MD&A would enable the
The Stock Exchange of Thailand The Company wishes to present the Management Discussion & Analysis (MD&A) on the operating and financial status for the 1st quarter of 2019. The MD&A would enable the
President The Stock Exchange of Thailand The Company wishes to present the Management Discussion & Analysis (MD&A) on the operating and financial status for the 2nd quarter of 2019. The MD&A would enable the
President The Stock Exchange of Thailand The Company wishes to present the Management Discussion & Analysis (MD&A) on the operating and financial status for the 2nd quarter of 2018. The MD&A would enable the
President The Stock Exchange of Thailand The Company wishes to present the Management Discussion & Analysis (MD&A) on the operating and financial status for the 3rd quarter of 2018. The MD&A would enable the
President The Stock Exchange of Thailand The Company wishes to present the Management Discussion & Analysis (MD&A) on the operating and financial status for the 3rd quarter of 2019. The MD&A would enable the
Manager The Stock Exchange of Thailand Ekachai Medical Care Public Company Limited and its subsidiaries (the “Company”) would like to clarify on the operating results for the first quarter